Zio AT ECG Monitoring System
Overview
The Zio AT ECG Monitoring System, developed by iRhythm Technologies, Inc., is a comprehensive ambulatory mobile cardiac telemetry (MCT) service designed for continuous, long-term monitoring of a patient’s electrocardiogram (ECG) data. It aims to simplify cardiac monitoring by providing uninterrupted recording and timely arrhythmia detection. The system consists of a Zio AT patch ECG monitor, a wireless gateway for data transmission, and the Zio ECG Utilization Software (ZEUS) which incorporates a deep-learned, FDA-cleared AI algorithm for analysis and reporting.
The Zio AT patch is a single-use, flexible, lightweight, and water-resistant device that can be worn for up to 14 days during routine activities, including showering and sleeping, without requiring battery changes or charging. It captures both patient-triggered and automatically detected symptomatic and asymptomatic cardiac events. Data is transmitted wirelessly to a monitoring center, and comprehensive end-of-wear reports are generated for clinicians, with a high rate of physician agreement.
The system is supported by the ZioSuite® clinician portal and a provider mobile app for report interpretation and patient management, as well as the MyZio® patient app for symptom logging and educational content. iRhythm Technologies emphasizes robust data security, privacy practices, and compliance with industry standards, including HIPAA, SOC 2 Type II certification, and GDPR.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Wearable Zio AT patch for continuous ECG recording
- Wireless gateway for real-time data transmission
- FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection
- Continuous, uninterrupted ECG recording for up to 14 days
- Detection of symptomatic and asymptomatic cardiac events
- Comprehensive end-of-wear reports for clinicians
- ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation
- MyZiou00ae patient mobile app for symptom logging and education
- Water-resistant and lightweight patient-centered design
- No battery changes or charging required during wear
Use Cases
- Detection and diagnosis of irregular heart rhythms, including atrial fibrillation (AF)
- Long-term ambulatory cardiac monitoring for transient symptoms (palpitations, dizziness, syncope)
- Monitoring patients post-stroke or TIA to identify underlying cardiac arrhythmias
- Post-procedure monitoring, such as after transcatheter aortic valve replacement (TAVR)
- Reducing hospital stays for patients presenting with syncope
- Providing actionable heartbeat data for clinical decision-making
What Physicians Need to Know
Leverage the Zio AT's extended, continuous monitoring capabilities for a higher diagnostic yield, especially for infrequent or asymptomatic arrhythmias that might be missed by shorter-term monitors. Utilize the AI-powered analysis and technician review for efficient and accurate reports, and integrate the system with your EHR for streamlined workflows and patient management. While effective for mobile cardiac telemetry, be mindful of its contraindications for critical care patients or situations requiring immediate real-time intervention for life-threatening arrhythmias. Encourage patients to actively use the MyZio app for symptom logging to enhance the correlation between symptoms and detected rhythms.
The Zio AT ECG Monitoring System offers comprehensive integration capabilities designed to enhance clinical workflow efficiency. It integrates directly with Electronic Health Record (EHR) systems, including Epic via the Aura network, enabling seamless electronic ordering, secure transmission of results, and direct interpretation of Zio reports within the EHR environment. This HL7-compatible integration simplifies data collection, reduces errors, and improves interdisciplinary access to patient cardiac data. Additionally, the MyZio patient app provides a direct channel for patient engagement, allowing for digital symptom logging and access to educational content, further integrating the patient's experience into the overall monitoring process.
Details
| Category | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Contact for pricing — Not publicly disclosed; typically involves service fees for monitoring and analysis. |
| Deployment | Cloud-based (data analytics and clinician portal) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated The Zio AT ECG Monitoring System, including its ZEUS System (software/algorithm component), has received multiple FDA 510(k) clearances. K181502, cleared on August 29, 2018, specifically pertains to an update of the ZEUS System's rhythm classification algorithm to a deep-learning basis. The device is a prescription-only outpatient cardiac telemetry device. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Zio AT ECG Monitoring System
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Zio AT ECG Monitoring System.
Zio Cardiac Monitor Introduction
General Physician
Frequently Asked Questions
Compare Zio AT ECG Monitoring System
VS
VS
VS
VS
Investors who backed Zio AT ECG Monitoring System
Funded through the company that built this tool.
